MENU
+Compare
NRC
Stock ticker: NASDAQ
AS OF
Nov 13 closing price
Price
$15.54
Change
+$0.11 (+0.71%)
Capitalization
353.23M

NRC stock forecast, quote, news & analysis

National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations... Show more

NRC
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for NRC with price predictions
Nov 12, 2025

NRC in upward trend: 10-day moving average crossed above 50-day moving average on November 10, 2025

The 10-day moving average for NRC crossed bullishly above the 50-day moving average on November 10, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 28, 2025. You may want to consider a long position or call options on NRC as a result. In of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NRC just turned positive on October 20, 2025. Looking at past instances where NRC's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

NRC moved above its 50-day moving average on November 04, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NRC advanced for three days, in of 297 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 177 cases where NRC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NRC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NRC broke above its upper Bollinger Band on October 28, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (24.691) is normal, around the industry mean (20.827). P/E Ratio (21.958) is within average values for comparable stocks, (113.023). NRC's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.450). Dividend Yield (0.031) settles around the average of (0.027) among similar stocks. P/S Ratio (2.554) is also within normal values, averaging (68.870).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NRC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NRC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

A.I.Advisor
published Dividends

NRC paid dividends on October 10, 2025

National Research Corp NRC Stock Dividends
А dividend of $0.12 per share was paid with a record date of October 10, 2025, and an ex-dividend date of September 26, 2025. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Teladoc Health (NYSE:TDOC).

Industry description

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

Market Cap

The average market capitalization across the Services to the Health Industry Industry is 2.24B. The market cap for tickers in the group ranges from 9 to 47.81B. VEEV holds the highest valuation in this group at 47.81B. The lowest valued company is MDPEF at 9.

High and low price notable news

The average weekly price growth across all stocks in the Services to the Health Industry Industry was -2%. For the same Industry, the average monthly price growth was -9%, and the average quarterly price growth was 10%. TXG experienced the highest price growth at 26%, while MGRX experienced the biggest fall at -35%.

Volume

The average weekly volume growth across all stocks in the Services to the Health Industry Industry was -26%. For the same stocks of the Industry, the average monthly volume growth was 23% and the average quarterly volume growth was 10%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 56
P/E Growth Rating: 70
Price Growth Rating: 61
SMR Rating: 84
Profit Risk Rating: 95
Seasonality Score: 3 (-100 ... +100)
View a ticker or compare two or three
NRC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a provider of market research services for the healthcare industry

Industry ServicestotheHealthIndustry

Profile
Fundamentals
Details
Industry
Servicestothe Health Industry
Address
1245 Q Street
Phone
+1 402 475-2525
Employees
435
Web
https://www.nrchealth.com